Hepatitis B Reactivation Rate and Fate Among Multiple Myeloma Patients Receiving Regimens Containing Lenalidomide and/or Bortezomib

Objective: Reactivation of the hepatitis B virus (HBV) refers to an increase in HBV replication in a patient with inactive or resolved HBV. In this retrospective study, our aim is to present and compare HBV reactivation in multiple myeloma (MM) patients who received lenalidomide and/or bortezomib at...

Full description

Bibliographic Details

Published in:	Turkish Journal of Hematology
Main Authors:	Pınar Ataca Atilla, Merih Yalçıner, Erden Atilla, Ramazan İdilman, Meral Beksaç
Format:	Article
Language:	English
Published:	Turkish Society of Hematology 2019-11-01
Subjects:	hepatitis b reactivation bortezomib lenalidomide multiple myeloma antiviral therapy
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-29895